摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-Diisopropyloxy-pyrimidin | 7306-77-6

中文名称
——
中文别名
——
英文名称
2,4-Diisopropyloxy-pyrimidin
英文别名
2,4-diisopropoxy-pyrimidine;2,4-Di(propan-2-yloxy)pyrimidine
2,4-Diisopropyloxy-pyrimidin化学式
CAS
7306-77-6
化学式
C10H16N2O2
mdl
——
分子量
196.249
InChiKey
KPEICDRSPXMPJM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    44.2
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Process for Producing Olefin Copolymerization Catalyst and Process for Producing Olefin Copolymer
    申请人:NAKAHARA Shinya
    公开号:US20080227937A1
    公开(公告)日:2008-09-18
    A process for producing an olefin copolymerization catalyst, comprising the step of contacting, with one another, (A) a solid catalyst component containing a titanium atom, a magnesium atom and a halogen atom, (B) an organoaluminum compound and/or organoaluminumoxy compound, and (C) a nitrogen-containing aromatic heterocyclic compound, whose one or more carbon atoms adjacent to its nitrogen atom are linked to an electron-donating group, or a group containing an electron-donating group; and a process for producing an olefin copolymer using the an olefin copolymerization catalyst.
  • US7605215B2
    申请人:——
    公开号:US7605215B2
    公开(公告)日:2009-10-20
  • [EN] PIPERIDYL DERIVATIVES<br/>[FR] DERIVES DE PIPERIDYLE
    申请人:FUJISAWA PHARMACEUTICAL CO
    公开号:WO2004111000A2
    公开(公告)日:2004-12-23
    A compound of the formula (I): wherein R1, R2, R8, R9 and R10 are each as defined in the description, and -X- is -NH or -O-,Y is (II), (III), (IV), etc., and -Z- is bond or (V) in which R3, R4, R5, R6, R7, and R11 are each as defined in the description, or a salt thereof. The object compound of the present invention has pharmacological activities such as Tachykinin antagonism, and is useful for manufacture of a medicament for treating or preventing Tachykinin-mediated diseases.
查看更多